Health

Democracy, demographics, digitalisation at European Health Forum Gastein
Est. 1minEurope’s health landscape is in constant motion, and the EU’s digital transformation aims to reset this landscape. The European Health Forum Gastein took stock of today’s challenges and the impact of the ‘3Ds’ - democracy, demographics, and digitalisation.

GOALSCORE project, fighting domestic violence through football
Est. 1minTo help tackle violence against women, the EU has launched GOALSCORE, an innovative project aiming to raise awareness and promote football institutional support for gender equality.

GOALSCORE – Global social inclusion: innovative actions against gender differences and prejudice in general
Est. 1minGOALSCORE - GlObAL Social inclusion: innovative aCtiOns against gender diffeRencEs and prejudice in general

Getting the balance right: AI, digitalisation, and respiratory medicine
Est. 1minRespiratory diseases are increasingly exacerbated by climate change and worsening air pollution. This special report examines how technology and policy can improve respiratory health.

TARGET – YouTh footbAll players as ambassadoRs for GEnder equaliTy
Est. 1minThe initiative focuses on coach training to promote gender equality within teams, integrating STEM and self-efficacy. A communication campaign will amplify the message across the EU, making TARGET a pioneering effort to address societal gender disparities through the popularity of football.

Antimicrobial resistance fight needs more ambition, new alliances and strategies
Est. 1minIn 2019 alone it’s estimated that AMR was directly responsible for 1.27 million deaths globally. That number could reach 10 million deaths by 2050, mostly in low- and middle-income countries. New alliances, new medicines, and new AMR strategies are needed.

Europe’s personalised medicine sector boosted by Sino-EU PerMed project
Est. 1minThe Sino-EU PerMed project, launched in January 2020, is a bi-regional consortium of six partners from governmental, funding and research organisations to promote personalised medicine cooperation between Europe and China.

Alzheimer’s Disease: detection, diagnosis, treatment
Est. 1minIt is estimated that over 7 million people are living with Alzheimer's Disease in Europe, and there is increasing concern about the ability to combat the disease with Europe's ageing population. In this series of articles, Euractiv will explore the state …

Europe’s human-animal bond, a special report on EU companion animals
Est. 1minA Human-Animal Bond Report was launched at the EU Companion Animals Stakeholder Summit on 20 March in Brussels, advocating advancements in companion animal policy to improve human and animal health and wellbeing.

Europe’s new Health Technology Assessment Regulation (HTAR) on the horizon
Est. 1minIn early 2025, Europe will implement a uniform, pan-EU framework under the new Health Technology Assessment Regulation (HTAR), addressing disparities in evaluating the clinical value of pharmaceuticals and medical devices.

Europe needs new 360 rare diseases strategy
Est. 1minRare Disease Day, 29 February, marks a moment when an estimated 30 million people living with rare diseases across Europe gain a louder voice. Europe now has a generational opportunity to scale up programmes capable of improving millions of lives.

The future of snus in Europe
Est. 1minThe EU executive is currently conducting a comprehensive evaluation of the EU legislative framework on tobacco control, the so-called Tobacco Products Directive (TPD), including via wide public consultations. The existing Directive covers traditional cigarettes and novel products and has imposed severe restrictions.

Diabetes care in Europe: The path forward
Est. 1minThere are millions of people in Europe who are affected by diabetes and related conditions. This number is only expected to grow in the coming years. However, with technological advancements, it is possible that those affected by the disease are able …

Navigating challenges: Start-ups in the evolving health-tech landscape
Est. 1minIn the dynamic landscape of the EU's health-tech market, start-ups face a myriad of challenges as they strive to innovate and carve out a niche in an industry characterised by rapid technological advancements and complex regulatory landscapes. In these articles, Euractiv …

The challenges cancer survivors face in Europe
Est. 1minIn cancer care, increasing survivorship comes with its own set of challenges, which include addressing the lasting physical and psycho-social impacts of the disease. In these articles, Euractiv looks at what is needed so that cancer survivors live their lives as …

Transplantation in the EU: From the waiting lists to post-transplantation journey
Est. 1minMedical technology innovation and policy advancements are improving the transplantation experience for thousands of people in the European Union.

Navigating care pathways for stroke survivors across the EU
Est. 1minAs the focus across the EU is usually on the prevention of stroke, post-stroke survivors are often left behind, without no national plans that take into account the need for a continuation of treatment after their discharge from medical institutions.

The complexity and rewards of gene treatments for rare diseases
Est. 1minGene therapies can transform the approach to rare diseases and improve the quality of life for patients. But developing and accessing them is hampered by regulatory burdens, cost and reimbursment schemes. In this special report, Euractiv takes a look at gene …

Building a resilient EU health union
Est. 1minThe recent years have been generous for EU health policy. COVID-19 pushed forward the creation of the European Health Union and boosted the creation of health policy files. In times of ongoing challenges that healthcare systems across the EU have …

Antimicrobial resistance: A threat that can no longer be ignored
Est. 2minDuring the European Health Forum, representatives of the pharmaceutical industry, EU institutions and patient associations discussed the next steps in fighting the ever-growing threat of antimicrobial resistance (AMR). From accessibility and incentives for research to awareness among the general public, …

Medicine information leaflets: Paper, digital or both?
Est. 1minThe European Commission's proposed pharmaceutical strategy leaves it to the countries to decide whether the medicine information leaflet is in paper format electronic, or both. However, moving exclusively towards the electronic version could risk leaving behind those lacking digital skills.

Hampered access to innovative cancer drugs in Spain
Est. 1minMedical societies, patient associations, and independent experts are pressing for expedited access to innovative cancer treatments in Spain, citing a noticeable lag and lack of alternatives in the process. Spain faces a "structural problem" when assessing and funding innovative cancer drugs. …

How worsening air quality affects the wellbeing of respiratory disease patients
Est. 1minClimate change is exacerbating threats to human health, especially affecting the health and well-being of those suffering from respiratory diseases. Air pollution is one of the biggest environmental threats to human health, causing at least 238,000 premature deaths per year, according …

The threat of anaphylaxis in Europe, unmasked
Est. 1minHow to prevent anaphylaxis and inequalities caused by divergent access to first-line emergency treatments across Europe?